# ResMed Inc. (RMD) FY2027 Q1 Revenue by Business Segment by Subsegment

- Company: ResMed Inc. (RMD)
- Statement: ResMed Inc. (RMD) FY2027 Q1 P&L / Income Statement, https://plicit.ai/financials/rmd/fy2027-q1-income-statement
- Period: 2026-07-01 to 2026-09-30
- Filing: Q1 FY2027 10-Q, filed 2026-10-30, accession number 0000943819-26-000089
- Page: https://plicit.ai/financials/rmd/fy2027-q1-income-statement/revenue-by-business-segment-by-subsegment
- Chart image: https://plicit.ai/charts/rmd-fy2027-q1-revenue-by-business-segment-by-subsegment-sankey.png

## Chart details: Revenue by Business Segment by Subsegment

Income statement for 2026-07-01 through 2026-09-30. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenue**: 1,414,814,000 US dollars
- **Cost of sales**: 544,247,000 US dollars
- **Gross profit**: 870,567,000 US dollars
- **Total operating expenses**: 417,583,000 US dollars
- **Income from operations**: 452,984,000 US dollars
- **Total other income (loss), net**: 86,171,000 US dollars
- **Income before income taxes**: 539,155,000 US dollars
- **Income taxes**: 120,742,000 US dollars
- **Net income**: 418,413,000 US dollars
- **Residential Care Software**: 155,012,000 US dollars
- **Sleep and Breathing Health - Devices**: 720,292,000 US dollars
- **Sleep and Breathing Health - Masks and other**: 539,510,000 US dollars
- **Total operating expenses**: 417,583,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Key Takeaways

- Masks and other rose $50.37 M, while devices added $39.98 M over the year.
- Devices still take 57% of Sleep and Breathing Health sales, but masks are catching up.
- Masks and other rose to 38% of total sales this quarter, from 37% a year earlier.
- Residential Care Software fell $11.12 M, the only piece shrinking as total sales grew 5.9%.
- Devices alone brought in $720.29 M, which is 51% of all sales, so one product line carries the business.

## The Unvarnished Truth

### Masks and other grew 10%, outpacing devices at 6%.

Masks and other rose $50.37 M this quarter, to $539.51 M, against $489.14 M a year earlier; devices rose $39.98 M, to $720.29 M. The masks line grew faster, and it is now 43% of Sleep and Breathing Health sales, up from 42% a year earlier. Residential Care Software fell $11.12 M in the same period, so sleep products carried the total, which grew 5.9%. The MD&A says the planned discontinuation of the Astral device cut life support device sales, partially offsetting growth.

Why did masks outrun devices? The MD&A gives one shared cause for both lines: the increase in net revenue on devices and masks was primarily attributable to increased demand and unit sales across the sleep health portfolio. It does not split masks from devices, so the faster masks line goes unexplained. The filing does give regional detail: Rest of World masks grew 12%, against 10% in the Americas, and currency explains part of that gap, since at constant currency Rest of World masks grew 11%.

Put together, the growth is shifting toward masks and other, and devices, the bigger line, are growing more slowly. Devices still carry the larger dollar base, $720.29 M against $539.51 M. The gap matters because it changes which product line the company leans on as it grows, and the filing does not say which way that goes. Will masks and other keep outgrowing devices once the Astral exit is out of the base, or was this quarter's gap a one-off?

## Intelligent Insights for Investors

### What is inside the biggest piece of ResMed's sales?

Sleep and Breathing Health is the biggest piece: its products brought in 89% of sales this quarter, and Devices made up 57% of them. Masks and other made up the other 43%.

### What drove the change in ResMed's biggest business over the past year?

Mostly Masks and other: it added $50.37 M of the $90.36 M rise in revenue from Sleep and Breathing Health over the year. That is 56% of the group's growth.

## Intelligent Insights for Lenders

### How much does ResMed depend on its biggest piece of sales?

Heavily: Sleep and Breathing Health - Devices brought in 51% of total sales this quarter, against 38% for Masks and other, the next largest.

## Intelligent Insights for Employees

### Which part of sales by product grew fastest over the past year?

Masks and other grew fastest: up 10% this quarter, against 6% for devices.

## Intelligent Insights for Suppliers

### Does one product line dominate ResMed's largest business?

Yes: Devices made up 57% of the Sleep and Breathing Health products ResMed lists this quarter, against 43% for Masks and other.
